Eefke Petersen

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 605 citations · Full text

Cardiovascular Disease After Hodgkin Lymphoma Treatment

Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus et al. · JAMA Internal Medicine · 2015 · 481 citations

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

Rick Admiraal, Stefan Nierkens, Moniek A. de Witte et al. · The Lancet Haematology · 2017 · 209 citations · Full text

Survival Outcomes, Transplantation, Autoimmune Disease +14

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

Frédéric Baron, Myriam Labopin, Dietger Niederwieser et al. · Leukemia · 2012 · 187 citations · Full text

Graft-versus-host Disease, Transplantation, Marrow Transplantation +9

Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma

Leo F. Verdonck, A. W. Dekker, Henk M. Lokhorst et al. · Blood · 1997 · 162 citations · Full text